These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 34743290)

  • 1. Prostate cancer treatment and the relationship of androgen deprivation therapy to cognitive function.
    Reiss AB; Saeedullah U; Grossfeld DJ; Glass AD; Pinkhasov A; Katz AE
    Clin Transl Oncol; 2022 May; 24(5):733-741. PubMed ID: 34743290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
    Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
    Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood.
    Reiss AB; Gulkarov S; Pinkhasov A; Sheehan KM; Srivastava A; De Leon J; Katz AE
    Medicina (Kaunas); 2023 Dec; 60(1):. PubMed ID: 38256338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Impairment: A Major Adverse Event in Prostate Cancer Patients Treated With Androgen Deprivation Therapy.
    Masuda H
    Anticancer Res; 2023 Jan; 43(1):305-309. PubMed ID: 36585176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen deprivation therapy in prostate cancer: anticipated side-effects and their management.
    Kim HS; Freedland SJ
    Curr Opin Support Palliat Care; 2010 Sep; 4(3):147-52. PubMed ID: 20592607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
    BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of androgen deprivation therapy in prostate cancer patients.
    Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive problems in patients on androgen deprivation therapy: a qualitative pilot study.
    Wu LM; Diefenbach MA; Gordon WA; Cantor JB; Cherrier MM
    Urol Oncol; 2013 Nov; 31(8):1533-8. PubMed ID: 22975107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen deprivation therapy: evidence-based management of side effects.
    Ahmadi H; Daneshmand S
    BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks associated with cognitive function and management strategies in the clinical use of ADT: a systematic review from clinical and preclinical studies.
    Cui MF; Chen LM; Jiang C; Ma BZ; Yuan FW; Zhao C; Liu SM
    Support Care Cancer; 2024 Jul; 32(8):561. PubMed ID: 39085696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone Recovery Profiles After Cessation of Androgen Deprivation Therapy for Prostate Cancer.
    Nascimento B; Miranda EP; Jenkins LC; Benfante N; Schofield EA; Mulhall JP
    J Sex Med; 2019 Jun; 16(6):872-879. PubMed ID: 31080102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive effects of hormone therapy in men with prostate cancer: a review.
    Nelson CJ; Lee JS; Gamboa MC; Roth AJ
    Cancer; 2008 Sep; 113(5):1097-106. PubMed ID: 18666210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual Motivators and Endorsement of Models Describing Sexual Response of Men Undergoing Androgen Deprivation Therapy for Advanced Prostate Cancer.
    Fode M; Mosholt KS; Nielsen TK; Tolouee S; Giraldi A; Østergren PB; Azawi N
    J Sex Med; 2020 Aug; 17(8):1538-1543. PubMed ID: 32448679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different androgen deprivation therapies might have a differential impact on cognition - An analysis from a population-based study using time-dependent exposure model.
    Hong JH; Huang CY; Chang CH; Muo CH; Jaw FS; Lu YC; Chung CJ
    Cancer Epidemiol; 2020 Feb; 64():101657. PubMed ID: 31918180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of androgen deprivation therapy and strategies to mitigate them.
    Nguyen PL; Alibhai SM; Basaria S; D'Amico AV; Kantoff PW; Keating NL; Penson DF; Rosario DJ; Tombal B; Smith MR
    Eur Urol; 2015 May; 67(5):825-36. PubMed ID: 25097095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
    Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
    Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
    Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
    J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent androgen deprivation therapy in advanced prostate cancer.
    Alva A; Hussain M
    Curr Treat Options Oncol; 2014 Mar; 15(1):127-36. PubMed ID: 24395278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer.
    Mohamad NV; Soelaiman IN; Chin KY
    Endocr Metab Immune Disord Drug Targets; 2017 Nov; 17(4):276-284. PubMed ID: 28925899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.